Carmela Abraham, PhD
Carmela R. Abraham, Ph.D., has devoted her entire career to the study of aging and Alzheimer’s disease (AD). She obtained her B.Sc. in Biology at Tel Aviv University and a Ph.D. in Neuroscience at Harvard University. She is Professor Emerita of Biochemistry and Pharmacology & Experimental Therapeutics at Boston University School of Medicine. Dr. Abraham’s research is both basic and translational. Her basic research focuses on understanding the pathologic mechanisms leading to AD and other neurodegenerative diseases. Dr. Abraham studies ways to protect the nerve cells that die in these diseases and, thus, prevent brain dysfunction. Her group discovered that the Klotho protein, whose levels decrease with age, is neuroprotective, anti-oxidative and anti-inflammatory. She is a co-founder of Klogenix (formerly Klogene), a biotech startup targeting prevention and treatment of age-related diseases.